Navigation Links
Oclaro Launches Eye-Safe High Power Laser Diodes at LASER 2009
Date:6/11/2009

SAN JOSE, Calif., June 11 /PRNewswire-FirstCall/ -- Oclaro, Inc. (Nasdaq: OCLR), a provider of optical components for industrial applications, has entered the eye-safe wavelength market with laser diode single emitter and bar products emitting at around 1.5 micrometer (um). The new long-wavelength devices target eye-safe applications in defense, material processing and medical markets.

Eye-safe standards are important in environments where there is risk of exposure to laser light. Eye-safe lasers emit light at wavelengths above 14xx nm, as light in this range is largely absorbed by the cornea before reaching the more sensitive retina. The retina can be seriously damaged by just micro-seconds of exposure to high power light at shorter wavelengths.

15xx and 14xx nm laser diode bar products deliver up to 30W continuous wave (CW) output power and are offered with a micro-channel or a passive Cu cooler configuration. The bars come with a fill factor of 30 percent and an emitter pitch of 500um, making them ideally suited for fiber coupled and pump laser applications.

The single emitter laser diodes emit 2W output power at 1470nm from a 90um stripe and are available on a CMount or in a 105um fiber coupled configuration. The fiber coupled version is built on the proven Oclaro platform for single emitter fiber laser pump modules, enabling high volume, scalable, and cost-effective manufacturing.

"The extension of our high performance laser diode bar and single emitter laser diodes into the long-wavelength range is an important step for Oclaro, addressing increased demand for eye-safe lasers, particularly in defense and medical markets," said Oclaro product marketing director, Karlheinz Gulden. "We have been able to deliver the high power and high reliability qualities with which Oclaro is associated at wave
'/>"/>

SOURCE Oclaro, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
2. UPMC Health Plan Launches New Personal Health Record
3. HealthInsuranceFinders.com Launches Video Contest for Young Directors
4. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
5. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
6. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
7. Mannatech Launches Phase One of New Sales and Training Tools
8. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
9. Actavis Launches Carvedilol Tablets in the U.S.
10. MedQuist Re-launches New, Improved Web Site
11. Elsevier launches new journal: Stem Cell Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... WEDNESDAY, May 22 (HealthDay News) -- Fish oil ... 2 diabetes, new research suggests. The ... levels of a hormone called adiponectin that,s linked ... of this hormone in the bloodstream have also ... disease. "While prior animal studies found fish ...
(Date:5/22/2013)... at Massachusetts General Hospital (MGH) one of the ... half rated the training they had received in addiction ... Significant numbers felt unprepared to diagnose or treat such ... response to the findings, recently published online in the ... residents, training in addiction medicine. , "Our residents ...
(Date:5/22/2013)... effect does a father,s depression have on his young son ... intimacy in their marriage, their children benefit, said a University ... their child, they need to be able to attend to ... stage and abilities, and notice whether he is getting frustrated ... said Nancy McElwain, a U of I professor of human ...
(Date:5/22/2013)... A new study suggests that disturbed sleep in ... and greater uncertainly about future success. However, ... appears to have a protective effect. , ... with depressed mood and greater uncertainty about future ... and from teachers were associated with significantly fewer ...
(Date:5/22/2013)... "power plants" that make energy to keep cells alive ... of the drug-resistant forms of cancer source of ... conclusion of a new study published in the journal ... and colleagues explain that doxorubicin and other common forms ... nucleus of cancer cells. Cancer cells divide and multiply ...
Breaking Medicine News(10 mins):Health News:Fish Oil Pills Might Cut Diabetes Risk, Researchers Say 2Health News:Survey points out deficiencies in addictions training for medical residents 2Health News:Survey points out deficiencies in addictions training for medical residents 3Health News:Survey points out deficiencies in addictions training for medical residents 4Health News:Good marriage can buffer effects of dad's depression on young children 2Health News:Parent and teacher support protects teens from sleep problems and depression 2
... Perrigo Company,(Nasdaq: PRGO ; TASE) today announced ... present at the 12th Annual Sidoti Emerging Growth,Institutional ... p.m. (ET) at the,Grand Hyatt Hotel in New ... global healthcare supplier that develops,manufactures and distributes over-the-counter ...
... will be a covered benefit immediately upon its ... members with chronic lymphocytic leukemia, INDIANAPOLIS, March ... effective immediately upon the drug,s,availability, its affiliate health ... coverage for Treanda. Specific benefit plans,may have variable ...
... Natural,Nutrition, Inc. (OTC Bulletin Board: NTNI) ... Finance, Inc., has been,renamed i-Nutrition, Inc. As the ... lending activities of CSI Business Finance have been ... all proceeds from loan payments,received going forward will ...
... Medicine and the Fox Chase Cancer Center have announced ... to join the Temple faculty and train Temple graduate ... share strengths and resources to collaborate on a new ... to those made between other medical schools and cancer ...
... Sharps Compliance Corp.,(OTC Bulletin Board: SCOM) ("Sharps" ... for small quantity generators of,medical waste, announced today ... Senior Vice President of Operations. Mr. Aladwani joins ... developer and,manufacturer of medical devices, where he served ...
... Southwestern Medical Center Patients Will Be the First to Benefit ... ... HOFFMAN ESTATES, Ill., March 24 Siemens Healthcare, (http://www.siemens.com/healthcare ) ... technology at UT Southwestern Medical,Center in Dallas. The facility will ...
Cached Medicine News:Health News:WellPoint's Health Plans to Cover Newly Approved Cancer Treatment 2Health News:Natural Nutrition Renames Former Business Lending Subsidiary i-Nutrition, Inc. 2Health News:Temple and Fox Chase partner on research and education 2Health News:Temple and Fox Chase partner on research and education 3Health News:Temple and Fox Chase partner on research and education 4Health News:Sharps Compliance Corp. Announces Appointment of Al Aladwani as its Senior Vice President of Operations 2Health News:Sharps Compliance Corp. Announces Appointment of Al Aladwani as its Senior Vice President of Operations 3Health News:Siemens Installs First High-Definition PET-CT 2
(Date:5/22/2013)... , May 22, 2013 Ranbaxy Laboratories ... Co., Ltd. (hereafter, Daiichi Sankyo), announced on May ... recent years to address past conduct under prior ... Daiichi Sankyo continues to support Ranbaxy ... conduct of the past which led to the ...
(Date:5/22/2013)... 22. Mai 2013  Grifols, ein globales ... Barcelona , Spanien, präsentierte die ... höhere Dosis von PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) den ... (AAT) auf ein Niveau anhebt, das innerhalb ... liegt. ATT-Mangel ist eine lebensbedrohliche, genetische Erkrankung, ...
(Date:5/22/2013)... and REHOVOT, Israel , May 22, ... ), a leading developer and provider of microRNA-based molecular ... , President and Chief Executive Officer of Rosetta Genomics, ... Healthcare Conference taking place from June 3-6, 2013 in ... on Tuesday, June 4 th at 2:00 p.m. ...
Breaking Medicine Technology:Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3
... N.J., Jan. 4, 2012   CANTEL MEDICAL CORP. ... CEO, will be presenting at the Needham & Company, ... scheduled for 9:20 AM ET on Wednesday, January 11, ... Q & A session immediately following the presentation. In ...
... marketers who need to calibrate multi-channel marketing and sales ... SyntheSight™ , a new proprietary pharmaceutical ... patent-pending IntelliScore™ , provides actionable insights ... answers. SyntheSight ...
Cached Medicine Technology:RMi Introduces SyntheSight™ Pharma Multi-Channel Optimization Suite 2RMi Introduces SyntheSight™ Pharma Multi-Channel Optimization Suite 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: